B+
Bull case
25%
Probability
Target price
$340.00
Analysis reference price unavailable
Analysis 2026-09-11 · RankAlpha Sentiment Codex
SYK
StrykerANYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Q2 showed broad, volume-led organic growth, substantial adjusted margin expansion and double-digit adjusted EPS growth despite the cyber disruption. Sustained recovery and delivery near the high end of FY2026 guidance could support a rerating.
Posture
Constructive
Lead driver
Sentiment
What changed
2 setup hits (3d) with net bearish as of 2026-09-10.
What can break
Execution risk against narrowed FY2026 organic-growth and adjusted-EPS guidance.
Momentum
16
Value
55
Sentiment
92
Setup hits (3d)
2 · Net Bearish
AI TargetsBase $305.00 · Bull $340.00 · Bear $235.00Analysis 2026-09-11; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-11 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Bearish
Target $381.57
Why
Momentum16 · Δ7d -18.5
Value55 · Δ7d -0.0
Sentiment92 · Δ7d -9.0
So what
Strength-led posture (Net Bearish). Favor watchlist adds and disciplined entries.
Confirming evidence
- • 2 setup hits (3d) with net bearish as of 2026-09-10.
- • Sentiment remains the lead driver in the composite, 7D delta -9.0.
Contradictions & invalidation
- • Execution risk against narrowed FY2026 organic-growth and adjusted-EPS guidance.
- • Large August director share sales may weigh on sentiment, although they do not establish an operating deterioration. [#SEC-FORM4-2026-08-20]
- • Recent headlines attribute share weakness to supply-chain issues and slower peripheral-vascular and hip sales, but those claims lack packet-level primary-source confirmation.
Catalyst clock
2026-07-30
Q2 recovery and narrowed FY2026 outlook
Lead driver: Sentiment · See AI snapshot
Momentum
16
9% active weight
Current posture
7d trendSoftening
Δ7d
-18.5
Δ21d
-25.0
Value
55
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.2
Sentiment
92
62% active weight
Current posture
7d trendSoftening
Δ7d
-9.0
Δ21d
-1.7
Why this grade
Composite grade A. Momentum 15.8 / Value 55.5 / Sentiment 92.2
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-11. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$305.00
Analysis reference price unavailable
Analysis 2026-09-11 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$235.00
Analysis reference price unavailable
Analysis 2026-09-11 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$127.22B
Beta
0.88
Shares Out
383.57M
P/E (TTM)
45.8
P/S (TTM)
5.47
P/FCF (TTM)
47.55
Rev YoY
+9.4%
EPS YoY
+44.5%
Gross Margin
+63.0%
Op Margin
+24.3%
Net Debt
$12.26B
Current Ratio
2.16
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data